Effects of a nitric oxide synthase inhibitor on 5-HT 1A receptor agonist 8-OH-DPAT-induced hyperphagia in rats

By Yamada J.   Sugimoto Y.   Yoshikawa T.   Horisaka K.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 23-26

Elsevier

Access to resources Recommend Favorite

Restraint accentuates the effects of 5-HT 2 receptor antagonists and a 5-HT 1A receptor agonist on lordosis behavior

By Uphouse L.   White S.   Harrison L.   Hiegel C.   Majumdar D.   Guptarak J.   Truitt W.A.  

Pharmacology Biochemistry and Behavior, Vol. 76, Iss. 1, 2003-08 ,pp. : 63-73

Elsevier

Access to resources Recommend Favorite

Cranial vascular effects of zolmitriptan, a centrally active 5-HT 1B/1D receptor partial agonist for the acute treatment of migraine

By MacLennan S.J.   Cambridge D.   Whiting M.V.   Marston C.   Martin G.R.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 191-197

Elsevier

Access to resources Recommend Favorite

The anxiolytic effects of flesinoxan, a 5-HT 1A receptor agonist, are not related to its neuroendocrine effects

By Groenink L.   Van der Gugten J.   Verdouw P.M.   Maes R.A.A.   Olivier B.  

European Journal of Pharmacology, Vol. 280, Iss. 2, 1995-07 ,pp. : 185-193

Elsevier

Access to resources Recommend Favorite

The 5-HT 1A receptor agonist Bayx3702 inhibits apoptosis induced by serum deprivation in cultured neurons

By Ahlemeyer B.   Glaser A.   Schaper C.   Semkova I.   Krieglstein J.  

European Journal of Pharmacology, Vol. 370, Iss. 2, 1999-04 ,pp. : 211-216

Elsevier

Access to resources Recommend Favorite